betahistine has been researched along with Atypical Cluster Headache in 1 studies
Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The unique pharmacologic properties of betahistine point to its potential future use as an antiobesity agent." | 4.84 | Betahistine: what's new on the agenda? ( Barak, N, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barak, N | 1 |
1 review available for betahistine and Atypical Cluster Headache
| Article | Year |
|---|---|
Betahistine: what's new on the agenda?
Topics: Animals; Betahistine; Clinical Trials as Topic; Cluster Headache; Drug Evaluation; Histamine Agonist | 2008 |